Clinical trial

The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia

NCT00197379 · Hamamatsu University, Other · Unknown status

Key facts

NCT number NCT00197379
Title The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia
Official title The Study for New Effect of Roxithromycin on Androgenetic Alopecia.
Lead sponsor Hamamatsu University, Other
Status Unknown status
Study type Interventional
Conditions Alopecia
Intervention type Drug
Interventions roxithromycin
Enrollment 20
Start date May 1, 2005
Completion Jan 1, 2007
First posted Sep 20, 2005
Last update posted Jul 29, 2010
Countries Japan

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies